Comparison of survival outcomes according of patients with metastatic gastric cancer receiving trastuzumab with systemic chemotherapy
Gi-Young Ha, Sung-Hyun Yang, Hye-Jin Kang, Hyo-Lak Lee, Jin Kim, Yun-Ju Kim, Hang-Jong Yu, Jong-Inn Lee, Sung-Ho Jin
Korean J Clin Oncol. 2020;16(2):63-70. Published online 2020 Dec 31 DOI: https://doi.org/10.14216/kjco.20011
Citations to this article as recorded by 
Deep learning-based prediction of HER2 status and trastuzumab treatment efficacy of gastric adenocarcinoma based on morphological features
Zhida Wu, Tao Wang, Junlin Lan, Jianchao Wang, Gang Chen, Tong Tong, Hejun Zhang
Journal of Translational Medicine.2025;[Epub] CrossRef
Identification of Immune Infiltrating Cell-Related Biomarkers in Early Gastric Cancer Progression
Chenguang Ji, Hongmei Cai, Xiaoxu Jin, Kaige Yin, Dongqiang Zhao, Zhijie Feng, Li Liu
Technology in Cancer Research & Treatment.2024;[Epub] CrossRef
Molecular Classifications in Gastric Cancer: A Call for Interdisciplinary Collaboration
Cristina Díaz del Arco, María Jesús Fernández Aceñero, Luis Ortega Medina
International Journal of Molecular Sciences.2024; 25(5): 2649. CrossRef
Low-level expression of human Epidermal growth Factor Receptor-2 (HER2) in High-Grade Mullerian Tumors: Implications for therapy decision making
Evi Abada, Kamaljeet Singh, Katrine Hansen, M. Ruhul Quddus
Gynecologic Oncology Reports.2023; 49: 101251. CrossRef